Crystal Structure and Mechanism of Activation of TANK-Binding Kinase 1

Cell Reports

Volumn 3, Issue 3, 2013, Pages 734-746

  Larabi, Amede ^a   Devos, Juliette M ^a   Ng, Sze Ling ^b   Nanao, Max H ^a   Round, Adam ^a   Maniatis, Tom ^b   Panne, Daniel ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; PHOSPHOTRANSFERASE; TANK BINDING KINASE 1; UBIQUITIN; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPHOSPHORYLATION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; ENZYME ACTIVATION; ENZYME CONFORMATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; STRUCTURE ANALYSIS; X RAY;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; HUMANS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; SCATTERING, SMALL ANGLE; X-RAY DIFFRACTION;

EID: 84875814149     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.01.034     Document Type: Article

References (54)

1. Adli M., Baldwin A.S. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation. J. Biol. Chem. 2006, 281:26976-26984.
2. Baker R., Ghosh S. Direct activation of protein kinases by ubiquitin. J. Mol. Cell Biol. 2009, 1:1-3.
3. Barbie D.A., Tamayo P., Boehm J.S., Kim S.Y., Moody S.E., Dunn I.F., Schinzel A.C., Sandy P., Meylan E., Scholl C., et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009, 462:108-112.
4. Boehm J.S., Zhao J.J., Yao J., Kim S.Y., Firestein R., Dunn I.F., Sjostrom S.K., Garraway L.A., Weremowicz S., Richardson A.L., et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007, 129:1065-1079.
5. Chau T.L., Gioia R., Gatot J.S., Patrascu F., Carpentier I., Chapelle J.P., O'Neill L., Beyaert R., Piette J., Chariot A. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?. Trends Biochem. Sci. 2008, 33:171-180.
6. Chen Z.J., Parent L., Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 1996, 84:853-862.
7. Chien Y., Kim S., Bumeister R., Loo Y.M., Kwon S.W., Johnson C.L., Balakireva M.G., Romeo Y., Kopelovich L., Gale M., et al. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 2006, 127:157-170.
8. Clark K., Plater L., Peggie M., Cohen P. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J. Biol. Chem. 2009, 284:14136-14146.
9. Clark K., Peggie M., Plater L., Sorcek R.J., Young E.R., Madwed J.B., Hough J., McIver E.G., Cohen P. Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 2011, 434:93-104.
10. Clément J.F., Meloche S., Servant M.J. The IKK-related kinases: from innate immunity to oncogenesis. Cell Res. 2008, 18:889-899.
11. De Bondt H.L., Rosenblatt J., Jancarik J., Jones H.D., Morgan D.O., Kim S.H. Crystal structure of cyclin-dependent kinase 2. Nature 1993, 363:595-602.
12. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997, 388:548-554.
13. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003, 4:491-496.
14. Friedman C.S., O'Donnell M.A., Legarda-Addison D., Ng A., Cárdenas W.B., Yount J.S., Moran T.M., Basler C.F., Komuro A., Horvath C.M., et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 2008, 9:930-936.
15. Fujita F., Taniguchi Y., Kato T., Narita Y., Furuya A., Ogawa T., Sakurai H., Joh T., Itoh M., Delhase M., et al. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol. Cell. Biol. 2003, 23:7780-7793.
16. Gatot J.S., Gioia R., Chau T.L., Patrascu F., Warnier M., Close P., Chapelle J.P., Muraille E., Brown K., Siebenlist U., et al. Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J. Biol. Chem. 2007, 282:31131-31146.
17. Gleason C.E., Ordureau A., Gourlay R., Arthur J.S., Cohen P. Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β. J. Biol. Chem. 2011, 286:35663-35674.
18. Goncalves A., Bürckstümmer T., Dixit E., Scheicher R., Górna M.W., Karayel E., Sugar C., Stukalov A., Berg T., Kralovics R., et al. Functional dissection of the TBK1 molecular network. PLoS ONE 2011, 6:e23971.
19. Guo B., Cheng G. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J. Biol. Chem. 2007, 282:11817-11826.
20. Guo J.P., Shu S.K., He L., Lee Y.C., Kruk P.A., Grenman S., Nicosia S.V., Mor G., Schell M.J., Coppola D., Cheng J.Q. Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. Am. J. Pathol. 2009, 175:324-333.
21. Hemmi H., Takeuchi O., Sato S., Yamamoto M., Kaisho T., Sanjo H., Kawai T., Hoshino K., Takeda K., Akira S. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 2004, 199:1641-1650.
22. Hicke L., Schubert H.L., Hill C.P. Ubiquitin-binding domains. Nat. Rev. Mol. Cell Biol. 2005, 6:610-621.
23. Ikeda F., Hecker C.M., Rozenknop A., Nordmeier R.D., Rogov V., Hofmann K., Akira S., Dötsch V., Dikic I. Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes. EMBO J. 2007, 26:3451-3462.
24. Israël A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb. Perspect. Biol. 2010, 2:a000158.
25. Karin M., Yamamoto Y., Wang Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 2004, 3:17-26.
26. Kishore N., Huynh Q.K., Mathialagan S., Hall T., Rouw S., Creely D., Lange G., Caroll J., Reitz B., Donnelly A., et al. IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2. J. Biol. Chem. 2002, 277:13840-13847.
27. Kornev A.P., Taylor S.S. Defining the conserved internal architecture of a protein kinase. Biochim. Biophys. Acta 2010, 1804:440-444.
28. Lei M., Robinson M.A., Harrison S.C. The active conformation of the PAK1 kinase domain. Structure 2005, 13:769-778.
29. Li J., Li J., Miyahira A., Sun J., Liu Y., Cheng G., Liang H. Crystal structure of the ubiquitin-like domain of human TBK1. Protein Cell 2012, 3:383-391.
30. Liu S., Chen Z.J. Expanding role of ubiquitination in NF-κB signaling. Cell Res. 2011, 21:6-21.
31. Ma X., Helgason E., Phung Q.T., Quan C.L., Iyer R.S., Lee M.W., Bowman K.K., Starovasnik M.A., Dueber E.C. Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. Proc. Natl. Acad. Sci. USA 2012, 109:9378-9383.
32. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 1997, 278:860-866.
33. Morton S., Hesson L., Peggie M., Cohen P. Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett. 2008, 582:997-1002.
34. Möser C.V., Kynast K., Baatz K., Russe O.Q., Ferreirós N., Costiuk H., Lu R., Schmidtko A., Tegeder I., Geisslinger G., Niederberger E. The protein kinase IKKε is a potential target for the treatment of inflammatory hyperalgesia. J. Immunol. 2011, 187:2617-2625.
35. Ng S.L., Friedman B.A., Schmid S., Gertz J., Myers R.M., Tenoever B.R., Maniatis T. IκB kinase epsilon (IKK(epsilon)) regulates the balance between type I and type II interferon responses. Proc. Natl. Acad. Sci. USA 2011, 108:21170-21175.
36. Olefsky J.M. IKKepsilon: a bridge between obesity and inflammation. Cell 2009, 138:834-836.
37. Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Kéri G., Mann M., Daub H. Large-scale proteomics analysis of the human kinome. Mol. Cell. Proteomics 2009, 8:1751-1764.
38. Ou Y.H., Torres M., Ram R., Formstecher E., Roland C., Cheng T., Brekken R., Wurz R., Tasker A., Polverino T., et al. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol. Cell 2011, 41:458-470.
39. Panne D., McWhirter S.M., Maniatis T., Harrison S.C. Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J. Biol. Chem. 2007, 282:22816-22822.
40. Péant B., Diallo J.S., Dufour F., Le Page C., Delvoye N., Saad F., Mes-Masson A.M. Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines. Prostate 2009, 69:706-718.
41. Peters R.T., Maniatis T. A new family of IKK-related kinases may function as I kappa B kinase kinases. Biochim. Biophys. Acta 2001, 1471:M57-M62.
42. Pomerantz J.L., Baltimore D. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 1999, 18:6694-6704.
43. Rushe M., Silvian L., Bixler S., Chen L.L., Cheung A., Bowes S., Cuervo H., Berkowitz S., Zheng T., Guckian K., et al. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. Structure 2008, 16:798-808.
44. Ryzhakov G., Randow F. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J. 2007, 26:3180-3190.
45. Shimada T., Kawai T., Takeda K., Matsumoto M., Inoue J., Tatsumi Y., Kanamaru A., Akira S. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int. Immunol. 1999, 11:1357-1362.
46. Steichen J.M., Kuchinskas M., Keshwani M.M., Yang J., Adams J.A., Taylor S.S. Structural basis for the regulation of protein kinase A by activation loop phosphorylation. J. Biol. Chem. 2012, 287:14672-14680.
47. Tenoever B.R., Ng S.L., Chua M.A., McWhirter S.M., García-Sastre A., Maniatis T. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 2007, 315:1274-1278.
48. Wang L., Li S., Dorf M.E. NEMO binds ubiquitinated TANK-binding kinase 1 (TBK1) to regulate innate immune responses to RNA viruses. PLoS ONE 2012, 7:e43756.
49. Xia Z.P., Sun L., Chen X., Pineda G., Jiang X., Adhikari A., Zeng W., Chen Z.J. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 2009, 461:114-119.
50. Xie X., Zhang D., Zhao B., Lu M.K., You M., Condorelli G., Wang C.Y., Guan K.L. IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc. Natl. Acad. Sci. USA 2011, 108:6474-6479.
51. Xu W., Harrison S.C., Eck M.J. Three-dimensional structure of the tyrosine kinase c-Src. Nature 1997, 385:595-602.
52. Xu G., Lo Y.C., Li Q., Napolitano G., Wu X., Jiang X., Dreano M., Karin M., Wu H. Crystal structure of inhibitor of κB kinase β. Nature 2011, 472:325-330.
53. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997, 91:243-252.
54. Zhao T., Yang L., Sun Q., Arguello M., Ballard D.W., Hiscott J., Lin R. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat. Immunol. 2007, 8:592-600.